Company profile: EKF Diagnostics
1.1 - Company Overview
Company description
- Provider of point-of-care diagnostic equipment measuring glucose, lactate, hemoglobin, hematocrit, and glycated hemoglobin (HbA1C), plus precision fermentation and custom bioprocessing services. Manufactures diagnostic enzymes (Arylacylamidase, Beta-Hydroxybutyrate Dehydrogenase, Salicylate Hydroxylase), offers the Beta-Hydroxybutyrate LiquiColor Reagent, and OEM services delivering end-to-end manufacturing from raw material sourcing to final packaging.
Products and services
- Precision Fermentation: EKF architects industrial-scale fermentation to produce enzymes, proteins, and biomolecules for industrial applications, using fermentors ranging from 300L to 14,500L for scalable output
- OEM Services: EKF delivers client-tailored end-to-end manufacturing systems that span raw material sourcing through final packaging, consolidating production workflows for OEM products
- Diagnostic Enzymes: EKF constructs clinical-reagent-grade Arylacylamidase, Beta-Hydroxybutyrate Dehydrogenase, and Salicylate Hydroxylase for use in clinical reagents and industrial applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to EKF Diagnostics
AES Chemunex
HQ: France
Website
- Description: Provider of conventional and novel culture media, rapid microbiology testing methods, laboratory instruments, and cytometry for microorganism detection, serving applications in the food, pharmaceutical, and cosmetic industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AES Chemunex company profile →
HistoCyte Laboratories
HQ: United Kingdom
Website
- Description: Provider of cell line controls and services for immunohistochemistry and in situ hybridization in cancer diagnosis, offering pre-cut slides and cell microarray blocks, dynamic range and standard controls, custom cell line development, biomarker characterization and assessment, and proof-of-concept and feasibility studies to improve assay confidence and assess assay quality.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HistoCyte Laboratories company profile →
LumiraDx
HQ: United Kingdom
Website
- Description: Provider of a point-of-care diagnostic platform delivering lab-comparable performance via a portable instrument, microfluidic test strips, and digital connectivity, plus cloud-based reporting, analytics, and decision support. Offers COVID-19 antigen and antibody tests and microfluidic immunoassays including NT-proBNP, D-Dimer, and INR.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LumiraDx company profile →
Flagship Biosciences
HQ: United States
Website
- Description: Provider of AI-enabled tissue profiling via the cTA pathology platform, offering SPATIALPlex spatial biology, Flagship Data Science for per-cell analysis integrating spatial proteomic/genomic data, multiplex IHC/FISH/CISH assay development and validation, genomics sequencing and gene expression, flow cytometry for hematopoietic neoplasms and immunophenotyping, and AI-driven digital pathology/image analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Flagship Biosciences company profile →
IDL Biotech
HQ: Sweden
Website
- Description: Provider of in vitro diagnostic (IVD) tests for the healthcare sector, developing, producing, and marketing worldwide. Active in oncology and bacteriology through manufacturing various tumor markers and a rapid Salmonella typhoid test.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IDL Biotech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for EKF Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to EKF Diagnostics
2.2 - Growth funds investing in similar companies to EKF Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for EKF Diagnostics
4.2 - Public trading comparable groups for EKF Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →